Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents (Q37046564)
Jump to navigation
Jump to search
scientific article published on 09 February 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents |
scientific article published on 09 February 2016 |
Statements
1 reference
Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents (English)
1 reference
Hagop Kantarjian
1 reference
Zeev Estrov
1 reference
Jorge Cortes
1 reference
Tapan Kadia
1 reference
Elias Jabbour
1 reference
Guillermo Garcia-Manero
1 reference
Marina Konopleva
1 reference
Andrew Futreal
1 reference
Courtney DiNardo
1 reference
Naval Daver
1 reference
Carlos Bueso-Ramos
1 reference
Curtis Gumbs
1 reference
Koichi Takahashi
1 reference
Keyur Patel
1 reference
Jianhua Zhang
1 reference
Michael Andreff
1 reference
1 reference
1 reference
Identifiers
1 reference